Caris Life Sciences, Inc. (CAI) compared with its closest peers (LMRI, GH, VCYT, CDNA, CSTL). Peer set by Healthcare Services; 10 comparable companies. First-party data.
Lumexa Imaging Holdings, Inc. Common Stock, Guardant Health, Veracyte, CareDx, Castle Biosciences, RadNet, Fulgent Genetics, BillionToOne, Natera and Fortrea share Caris Life Sciences's sub-industry, medical laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.13B | 656.4 |
| Guardant Health, Inc. (GH) | $22.13B | -30.8 |
| Veracyte, Inc. (VCYT) | $3.52B | 30.7 |
| CareDx, Inc (CDNA) | $2.63B | 22.3 |
| Castle Biosciences, Inc. (CSTL) | $1.07B | -46.9 |
| RadNet, Inc. (RDNT) | $6.05B | -285.0 |
| Fulgent Genetics, Inc. (FLGT) | $548.38M | -13.3 |
| BillionToOne, Inc. (BLLN) | $5.45B | 172.9 |
| Natera, Inc. (NTRA) | $48.53B | -150.7 |
| Fortrea Holdings Inc. (FTRE) | $1.74B | -1.6 |
| Sector P/E (Healthcare) | 21.9 |
| Industry P/E (Healthcare Services) | 25.4 |
CAI overview · CAI earnings · CAI financials · CAI KPIs · CAI documents · CAI ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.